http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2013172105-A1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4748 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57438 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
filingDate | 2013-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2016-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-WO2013172105-A1 |
titleOfInvention | Markers for detecting pancreatic cancer |
abstract | When glycoprotein C4BPA or PIGR is used as a marker for detecting pancreatic cancer, pancreatic cancer can be specifically determined by distinguishing it from chronic pancreatitis patients and healthy individuals. In addition, the prognostic status of patients with pancreatic cancer after surgery can be monitored. Furthermore, by using in combination with other pancreatic cancer markers such as CA19-9, it is possible to distinguish more specifically from patients with chronic pancreatitis and healthy individuals. |
priorityDate | 2012-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 83.